PharmTech Drug Digest 11.20
News|Articles|April 3, 2015

Catalent Acquires Australia’s Pharmapak Technologies

Catalent acquires Pharmapak Technologies, a pharmaceutical packaging company based in New South Wales, Australia.

 

Catalent announced on March 30, 2014 that it acquired Pharmapak Technologies, a pharmaceutical packaging business based out of New South Wales, Australia. Catalent currently operates a facility in Braeside, Victoria, where it produces oral-dose products to supply throughout Asia Pacific. The acquisition will give Catalent regional packaging options for its local production.

“This acquisition complements our industry-leading oral-dosage form development and manufacturing capabilities with a broader range of packaging options, from bulk supply to finished packs,” said Mark Bisset, president of Catalent Asia Pacific, in a press release. “Catalent has made substantial recent investments in Asia Pacific with a new facility in China, and last year we celebrated our 40th year in Japan with a new laboratory and the build-out of more manufacturing capacity. This latest investment is in response to strong, local market demand for both pharmaceutical, over-the-counter (OTC), and Complementary Medicine products.”

Source: Catalent


Related to this article

white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Green Chemistry Supply and Demand in Sustainable Pharma
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.